CRISPR/Cas9 editing of a deletion (c.2423delT) in exon 36 of the COL1A1 gene in OI-iPSCs was able to ameliorate their otherwise impaired capability for osteogenic differentiation and shows promise as a possible treatment for OI [326]. Here, COL1A1 is linked to osteogenesis imperfecta.